Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 1675 of 1710 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/29/21
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 04/18/17
End: 05/30/19
Due: 05/30/20
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 08/31/18
Due: 08/31/19
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 11/07/24
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 10/10/24
Due: 10/10/25
Phase: N/A
Priority: Normal
Start: 01/31/20
End: 07/01/24
Due: 07/01/25
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 05/31/21
Due: 05/31/22
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 10/31/03
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 11/30/13
Due: 11/30/14
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
Phase: N/A
Priority: Normal
Start: 02/12/24
End: 11/15/28
Due: 11/15/29
Phase: N/A
Priority: Normal
Start: 11/11/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 04/03/23
End: 10/13/25
Due: 10/13/26
Phase: N/A
Priority: Normal
Start: 04/07/22
End: 07/31/23
Due: 07/31/24
Phase: N/A
Priority: Normal
Start: 11/30/25
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 06/23/15
End: 04/28/18
Due: 04/28/19